Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice : Transplantation

Journal Logo

Original Clinical Science—General

Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

Fernández-Ruiz, Mario MD, PhD1,2,3; Bodro, Marta MD, PhD3,4; Gutiérrez Martín, Isabel MD5; Rodriguez-Álvarez, Regino MD, PhD6; Ruiz-Ruigómez, María MD, PhD1; Sabé, Núria MD, PhD3,7,8; López-Viñau, Teresa MD3,9; Valerio, Maricela MD, PhD2,10,11; Illaro, Aitziber PharmD12; Fortún, Jesús MD, PhD3,13,14; Salto-Alejandre, Sonsoles MD3,15; Cordero, Elisa MD, PhD3,15; Fariñas, María del Carmen MD, PhD3,16,17; Muñoz, Patricia MD, PhD2,10,11; Vidal, Elisa MD, PhD3,9,18; Carratalà, Jordi MD, PhD3,7,8; Goikoetxea, Josune MD, PhD6; Ramos-Martínez, Antonio MD, PhD19,20; Moreno, Asunción MD, PhD3,4; Aguado, José María MD, PhD1,2,3;  SOTIS Study Group

Author Information
Transplantation 107(3):p 762-773, March 2023. | DOI: 10.1097/TP.0000000000004312
  • Buy
  • SDC
  • Infographic

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid